18.06.2023, 1915 Zeichen

Marinomed: Marinomed Biotech AG announced the introduction of a new Carragelose eye drop product (MAM-1001-3), expanding the range of the marketed Carragelose OTC portfolio. The product has a valid certification under the Medical Device Directive (MDD) and is currently being prepared for marketing. “The introduction of Carragelose eye drops is a logical addition to our current OTC portfolio. This asset has an upright certification and is ready for partnering and marketing, thus will be generating revenues in the near to medium term,” explains Andreas Grassauer, CEO of Marinomed. “The product is intended to provide relief for dry eyes. Carragelose has excellent moisturizing properties and an outstanding safety profile. In addition, Carragelose is well known for its virus-blocking effectiveness.” With a first partnership for the eye drops already in place, a market launch in Austria is targeted for the first half of 2024.
Marinomed Biotech: weekly performance: -6.68%

DO & CO: Business year 2022/2023 is by far the strongest in terms of revenue in DO & CO's history. With revenue of € 1,419.35m (PY: € 705.20m) the catering company has doubled its revenue compared to the previous year. The EBITDA of the DO & CO group amounts to € 143.33m (PY: € 96.34m). Consolidated earnings before interest and tax (EBIT) of the DO & CO group amounted to € 85.71m, € 43.31m higher than in the previous year. Net result tripled in business year 2022/2023 to € 33.64m (PY: € 11.00m). "Due to high demand in all its divisions, DO & CO faced the challenge of acquiring new employees in all business divisions. DO & CO is proud to have hired above 3,000 new employees in the business year under review, each of whom has their own unique personality and a passion for hospitality", the company stated.
DO&CO: weekly performance: 11.35%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (15/06/2023)

Christian Drastil: Wiener Börse Plausch

SportWoche Podcast #107: Kave Atefie, Co-Founder gesund.co.at, Maradonas Balljunge, Rocky-Box-Double, BB King Vorgruppe

Bildnachweis

Aktien auf dem Radar:Palfinger, Immofinanz, Kapsch TrafficCom, Flughafen Wien, EuroTeleSites AG, Addiko Bank, Rosgix, Telekom Austria, RBI, SBO, Uniqa, ams-Osram, Oberbank AG Stamm, Agrana, Amag, CA Immo, Erste Group, EVN, FACC, OMV, Österreichische Post, VIG, Wienerberger, Warimpex, Henkel, Apple, Amgen, Deutsche Post, Vonovia SE, Beiersdorf, Münchener Rück.

---